CDH1 and breast cancer: For instance, in breast cancer, E-cadherin has an unexpected regulatory ability in tumorigenicity and hypoxia responses: E-cadherin loss is associated with slower tumor growth and loss of hypoxia response genes, which lead to reduced glycolytic capacity.